Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
File(s)
Author(s)
Pallett, Scott JC
Jones, Rachael
Randell, Paul
Davies, Gary W
Moore, Luke SP
Type
Journal Article
Date Issued
2021-05-01
Date Acceptance
2020-12-17
Citation
Lancet Infectious Diseases, 2021, 21 (5), pp.598-599
ISSN
1473-3099
Publisher
Elsevier
Start Page
598
End Page
599
Journal / Book Title
Lancet Infectious Diseases
Volume
21
Issue
5
Copyright Statement
Crown Copyright © 2021 Published by Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/33484647
PII: S1473-3099(20)30990-7
Subjects
COVID-19
Humans
Reinfection
SARS-CoV-2
Humans
COVID-19
SARS-CoV-2
Reinfection
1103 Clinical Sciences
1108 Medical Microbiology
1117 Public Health and Health Services
Microbiology
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2021-01-20